ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,442.00
2.14%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,707.85
-0.29%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) 뉴스

WGS GeneDx Holdings Corporation

19.66
0.16 (0.82%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
GeneDx Holdings Corporation WGS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.16 0.82% 19.66 08:08:44
개장가 저가 고가 종가 전일 종가
19.47 19.09 21.71 19.66 19.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202405:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/04/202421:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
05/04/202405:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/03/202421:30GLOBEGeneDx to Present Data at the 2024 American College of..
06/03/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
24/02/202406:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/02/202406:28EDGAR2Form 8-K - Current report
21/02/202406:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
02/02/202406:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
25/01/202406:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
24/01/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202422:58EDGAR2Form 8-K - Current report
08/01/202422:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
05/01/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
29/11/202306:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
21/11/202306:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
18/11/202306:15EDGAR2Form SC 13D/A - General statement of acquisition of..
04/11/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202305:33EDGAR2Form 8-K - Current report
31/10/202305:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
24/10/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202305:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
04/10/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202305:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
20/09/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202321:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
07/09/202305:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202321:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/08/202320:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
09/08/202309:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
09/08/202305:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/08/202305:13EDGAR2Form 8-K - Current report
09/08/202305:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/08/202321:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
28/07/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/07/202306:04EDGAR2Form 8-K - Current report
22/07/202310:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202320:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

최근 히스토리

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유